Welcome to our dedicated page for Ingersoll-Rand SEC filings (Ticker: IR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions. These filings offer detailed information on the company’s operations, governance, and financial performance across its Industrial Technologies and Services and Precision and Science Technologies segments.
Ingersoll Rand regularly files Current Reports on Form 8-K to disclose material events. Recent 8-K filings include reports on quarterly financial results, where the company furnishes earnings press releases that discuss segment orders, revenues, Adjusted EBITDA, and guidance, as well as filings related to board changes. For example, the company has filed 8-Ks describing the appointment of new independent directors and their committee assignments, including roles on the Compensation, Sustainability, and Nominating and Corporate Governance Committees.
Through this filings page, users can also review documents that explain how Ingersoll Rand uses non-GAAP financial measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Free Cash Flow Margin. The company’s disclosures describe how these metrics are calculated, why management and the board use them, and how they relate to liquidity, capital allocation, and performance evaluation.
Stock Titan enhances these regulatory documents with AI-powered summaries that help interpret key points from lengthy filings. As new IR filings are posted to EDGAR, they are updated here, allowing investors to quickly locate quarterly results, material event disclosures, and governance updates. Users interested in topics such as segment performance, capital allocation, director appointments, or the company’s use of non-GAAP metrics can use this page as a central reference for Ingersoll Rand’s official SEC reporting history.
Ingersoll Rand Inc. Chairman, President and Chief Executive Officer Vicente Reynal reported a planned stock transaction on January 16, 2026. He exercised 191,000 stock options at an exercise price of $10.61 per share and, on the same date, sold 191,000 shares of common stock at a weighted average price of $88.12, with individual sale prices ranging from $88.00 to $88.42. The sales were made under a pre‑established Rule 10b5‑1 trading plan adopted on May 22, 2025.
Following these transactions, Reynal directly held 193,186 shares of Ingersoll Rand common stock and 305,746 stock options. He also had indirect beneficial ownership of additional shares held in trusts: 147,802 shares in a trust for himself and his spouse, 75,000 shares in a trust for his descendants, and 22,500 shares in a trust for his spouse and descendants.
A holder of the issuer’s common stock has filed a notice under Rule 144 to sell 191,000 shares through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $16,829,996.54. The filing notes that there were 395,110,395 shares of this class outstanding at the time of the notice. The shares to be sold were acquired on 01/16/2026 by exercising a stock option originally granted on 05/10/2016, with the purchase price paid in cash.
Ingersoll Rand Inc. director Jerome M. Guillen filed an initial insider ownership report as of 01/01/2026. This Form 3 filing states that no securities of Ingersoll Rand Inc. are beneficially owned. The form is signed by an attorney-in-fact under a Power of Attorney, confirming the reporting setup for this new director but showing no current share holdings.
Ingersoll Rand Inc. expanded its Board of Directors to ten members and appointed Jerome Guillen as an independent director, effective January 1, 2026.
He will serve until the company’s 2026 Annual Meeting of Stockholders and will also join the Board’s Compensation Committee and Sustainability Committee. The Board determined that he meets New York Stock Exchange independence standards and the company’s Corporate Governance Guidelines, and he has no arrangements or related‑party transactions connected to his selection. As a non‑employee director, he will be compensated under Ingersoll Rand’s standard policy for non‑employee directors. The company also issued a press release announcing his appointment.
Ingersoll Rand Inc. insider trade: a company officer reported selling 1,477 shares of common stock on 12/01/2025 at a price of $80.627 per share. This transaction was reported on a Form 4 under insider reporting rules.
After this sale, the officer directly beneficially owns 12,153.179 shares of Ingersoll Rand common stock. The filer is identified as the company’s Vice President and Chief Accounting Officer, and the filing reflects a transaction by a single reporting person.
A shareholder of IR has filed a notice under Rule 144 to sell up to 1,477 shares of common stock through Fidelity Brokerage Services LLC. The shares have an indicated aggregate market value of 119,085.93, and the planned sale is listed for around 12/01/2025 on the NYSE. The shares to be sold were acquired from the issuer through restricted stock vesting on 02/22/2024 and 02/23/2024, in amounts of 459 and 1,018 shares as compensation. The filing also notes that 395,110,395 shares of this class of stock were outstanding, giving investors a sense of the overall share base relative to this planned sale.
Capital World Investors filed an amended Schedule 13G reporting a passive stake in Ingersoll Rand (IR). The firm is deemed to beneficially own 32,118,760 shares, representing 8.1% of the 397,452,515 shares believed outstanding. The filing lists sole voting power over 31,968,872 shares and sole dispositive power over 32,118,760 shares, with no shared voting or dispositive power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Ingersoll Rand (IR): Schedule 13G/A filed by Capital International Investors. The investor reports beneficial ownership of 51,326,399 shares of Ingersoll Rand common stock, representing 12.9% of the class. The filing cites 397,452,515 shares believed outstanding.
Capital International Investors reports sole voting power over 51,102,969 shares and sole dispositive power over 51,326,399 shares, with no shared voting or dispositive power. The certification states the securities “were acquired and are held in the ordinary course of business” and not for the purpose or effect of changing or influencing control. The date of event triggering this amendment is 09/30/2025.
Ingersoll Rand Inc. reported third‑quarter results in its 10‑Q. Q3 2025 revenue was $1,955.0 million (up from $1,861.0 million), with operating income of $375.5 million and diluted EPS of $0.61.
Year‑to‑date performance reflected non‑cash charges: goodwill impairment of $229.7 million, other intangible impairment of $36.1 million, and a loss on equity method investments of $127.1 million, leading to net income of $320.4 million (vs. $614.4 million a year ago). Cash from operations was robust at $856.7 million for the nine months ended September 30, 2025.
The company completed $496.1 million of acquisitions in 2025, including $193.7 million for TMIC/Adicomp. It used $703.3 million for share repurchases over the same period. As of September 30, 2025, cash was $1,176.6 million and long‑term debt was $4,786.7 million. Shares outstanding were 395,110,395 as of October 24, 2025.
Ingersoll Rand Inc. reported its financial results for the quarter ended September 30, 2025 and announced them in a press release dated October 30, 2025. The company furnished this press release as an exhibit so investors can review the full quarterly performance details. The information is provided under disclosure rules for results of operations and financial condition and is not treated as filed for liability purposes.